NDAQ compared with AZN: revenue, margins and what each company keeps, and the suppliers and customers both name

NDAQNasdaq, Inc.

Mkt capRevenueRevenue

AZNAstrazeneca PLC

Mkt capRevenueRevenue

Compare

NDAQNasdaq, Inc.

AZNAstrazeneca PLC

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

AZN: latest quarter not drawable.Method ›

Price

rebased to 0%

NDAQ, solidAZN, dashed

NDAQNasdaq, Inc.

106.25▲+0.61%· post 106.20

Mkt cap$59.0BRevenue$2.4BQ3 FY26Revenue$8.3BFY25

AZNAstrazeneca PLC

186.63▲+7.01%· post 186.35

ClosedOct 30 '26

Mkt cap$289.5BRevenue—Revenue—

Compare

ClosedOct 30 '26

NDAQNasdaq, Inc.

AZNAstrazeneca PLC

106.25▲+0.61%post 106.20

Price

186.63▲+7.01%post 186.35

$59.0B

Mkt cap

$289.5B

Q3 FY26$2.4B

Revenue

—

FY25$8.3B

Revenue

—

NDAQ106.25▲+0.61%vsAZN186.63▲+7.01%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NDAQ 25

HOODRobinhood Marketscustomer

UMBFUMB Financialcustomer

COLBColumbia Banking Systemcustomer

TCBITexas Capital Bancsharescustomer

21 more · NDAQ chain ›

Shared 0

No shared counterparties.

Only AZN 20

ARQTArcutis Biotherapeuticscustomer

GRALGrailsupplier

RCUSArcus Biosciencescustomer

NKTRNektar Therapeuticssupplier

Role chip = supplier or customerSource: SEC EDGAR

16 more · AZN chain ›